Codexis, Inc. (CDXS) stock
CDXSNasdaqIndustrial Organic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/3018% below fair value
$1.16+0.20 (+21.07%)
Close on Nov 13, 2026Market cap $127.03MP/E –Yield –
Codexis r&d expenses
Research and development expenses are spending on new products and technology.
Codexis's R&D Expenses for the twelve months ending Sep 30, 2026 was $47.46M, down 9.9% year over year. For fiscal 2025 it was $52.31M, up 13.1% from the year before. Over ten years it grew 9.7% a year on average. The highest annual figure on record is $80.10M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.31M | +13.1% |
| FY2024 | Dec 31, 2024 | $46.26M | -21.4% |
| FY2023 | Dec 31, 2023 | $58.89M | -26.5% |
| FY2022 | Dec 31, 2022 | $80.10M | +43.2% |
| FY2021 | Dec 31, 2021 | $55.92M | +26.6% |
| FY2020 | Dec 31, 2020 | $44.19M | +30.4% |
| FY2019 | Dec 31, 2019 | $33.87M | +13.0% |
| FY2018 | Dec 31, 2018 | $29.98M | +1.1% |
| FY2017 | Dec 31, 2017 | $29.66M | +33.4% |
| FY2016 | Dec 31, 2016 | $22.23M | +7.5% |
| FY2015 | Dec 31, 2015 | $20.67M | -9.1% |
| FY2014 | Dec 31, 2014 | $22.76M | -28.0% |
| FY2013 | Dec 31, 2013 | $31.61M | -44.3% |
| FY2012 | Dec 31, 2012 | $56.79M | -7.0% |
| FY2011 | Dec 31, 2011 | $61.05M | +16.5% |
| FY2010 | Dec 31, 2010 | $52.41M | -4.2% |
| FY2009 | Dec 31, 2009 | $54.73M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.59M | -9.2% |
| Q2 FY2026 | Jun 30, 2026 | $11.71M | -15.0% |
| Q1 FY2026 | Mar 31, 2026 | $11.45M | -11.5% |
| Q4 FY2025 | Dec 31, 2025 | $11.72M | -3.1% |
| Q3 FY2025 | Sep 30, 2025 | $13.87M | +20.5% |
| Q2 FY2025 | Jun 30, 2025 | $13.78M | +20.7% |
| Q1 FY2025 | Mar 31, 2025 | $12.94M | +15.1% |
| Q4 FY2024 | Dec 31, 2024 | $12.10M | +7.7% |
| Q3 FY2024 | Sep 30, 2024 | $11.51M | -15.8% |
| Q2 FY2024 | Jun 30, 2024 | $11.41M | -34.2% |
| Q1 FY2024 | Mar 31, 2024 | $11.25M | -32.5% |
| Q4 FY2023 | Dec 31, 2023 | $11.23M | -42.9% |
| Q3 FY2023 | Sep 30, 2023 | $13.66M | -37.4% |
| Q2 FY2023 | Jun 30, 2023 | $17.33M | -9.2% |
| Q1 FY2023 | Mar 31, 2023 | $16.66M | -14.6% |
| Q4 FY2022 | Dec 31, 2022 | $19.69M | +20.4% |
| Q3 FY2022 | Sep 30, 2022 | $21.82M | +43.9% |
| Q2 FY2022 | Jun 30, 2022 | $19.09M | +48.8% |
| Q1 FY2022 | Mar 31, 2022 | $19.50M | +68.5% |
| Q4 FY2021 | Dec 31, 2021 | $16.36M | +58.0% |
| Q3 FY2021 | Sep 30, 2021 | $15.17M | +26.3% |
| Q2 FY2021 | Jun 30, 2021 | $12.83M | +18.2% |
| Q1 FY2021 | Mar 31, 2021 | $11.57M | +5.5% |
| Q4 FY2020 | Dec 31, 2020 | $10.36M | +16.7% |
| Q3 FY2020 | Sep 30, 2020 | $12.01M | +37.9% |
| Q2 FY2020 | Jun 30, 2020 | $10.85M | +31.2% |
| Q1 FY2020 | Mar 31, 2020 | $10.97M | +36.8% |
| Q4 FY2019 | Dec 31, 2019 | $8.87M | +18.1% |
| Q3 FY2019 | Sep 30, 2019 | $8.71M | +10.0% |
| Q2 FY2019 | Jun 30, 2019 | $8.27M | +12.3% |
| Q1 FY2019 | Mar 31, 2019 | $8.02M | +11.7% |
| Q4 FY2018 | Dec 31, 2018 | $7.51M | -20.2% |
| Q3 FY2018 | Sep 30, 2018 | $7.92M | -1.7% |
| Q2 FY2018 | Jun 30, 2018 | $7.37M | +16.1% |
| Q1 FY2018 | Mar 31, 2018 | $7.18M | +22.9% |
| Q4 FY2017 | Dec 31, 2017 | $9.42M | +57.9% |
| Q3 FY2017 | Sep 30, 2017 | $8.06M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.35M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.84M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.96M | – |
See a number that looks wrong?